Questions raised by the Benelux CML Study Group: results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha2b for chronic myeloid leukemia.

Questions raised by the Benelux CML Study Group: results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha2b for chronic myeloid leukemia. Blood. 1998 Oct 15; 92(8):2984-7.

View in: PubMed

subject areas

Antineoplastic Agents, Alkylating
Antineoplastic Combined Chemotherapy Protocols
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Hydroxyurea
Interferon-alpha
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Meta-Analysis as Topic
Multicenter Studies as Topic
Patient Compliance
Patient Dropouts
Randomized Controlled Trials as Topic
Recombinant Proteins
Research Design
Treatment Outcome

authors with profiles

HAGOP M KANTARJIAN